Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.41 |
| ▸ | ALPL | P05186 | 1/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | GALK1 | P51570 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | CASP6 | P55212 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.41 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26103746 | 1.00 | LGALS8 (0.44) | LGALS8SLC6A2SYNJ2POLBKDM4E | |
| SCHEMBL2307255 | 1.00 | LGALS8 (0.44) | LGALS8SLC6A2SYNJ2POLBKDM4E | |
| SCHEMBL2307262 | 1.00 | LGALS8 (0.44) | LGALS8SLC6A2SYNJ2POLBKDM4E | |
| SCHEMBL2311527 | 0.92 | LGALS8 (0.47) | LGALS8SLC6A2 | |
| SCHEMBL2311523 | 0.92 | LGALS8 (0.47) | LGALS8SLC6A2 | |
| SCHEMBL7768969 | 0.89 | LGALS8 (0.51) | LGALS8SLC6A2SYNJ2POLBKDM4E | |
| SCHEMBL14376669 | 0.88 | LGALS8 (0.42) | LGALS8CA1CA2CA9MEN1 | |
| SCHEMBL14376670 | 0.87 | LGALS8 (0.40) | LGALS8CA1CA2CA9MEN1 | |
| SCHEMBL15501143 | 0.87 | ANPEP (0.38) | LGALS8SYNJ2POLBKDM4EABL1 | |
| SCHEMBL2003090 | 0.87 | ANPEP (0.38) | LGALS8SYNJ2POLBKDM4EABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170112924-A1 | SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF | K2 HEALTHVENTURES LLC, AS CANADIAN COLLATERAL AGENT | 2017-04-27 | — | — | US | disclosed |
| US-20140328876-A1 | SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF | VARIATION BIOTECHNOLOGIES INC. (CA) | 2014-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140328876-A1 | SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF | MPL, CD47, PLTP | LGALS8 311/4885SLC6A2 4550/4885SYNJ2 548/4885 |
| US-20170112924-A1 | SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF | MPL, CD47, PLTP | LGALS8 308/4885SLC6A2 4452/4885SYNJ2 333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.